Finance

Lists
Why is 688578 up 5.02%?
Dive Deeper
688578:SHA
Shanghai Allist Pharmaceuticals Co Ltd
CNÂ¥111.58
+5.02%
(+5.33) 1D
Sep 30, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688578...
Open
CNÂ¥105.50
High
CNÂ¥112.36
Low
CNÂ¥105.20
Mkt. cap
50.21B
Avg. vol.
6.27M
Volume
0.00
Dividend
1.08%
Quarterly dividend
CNÂ¥0.30
Ex-dividend date
Sep 2, 2026
P/E ratio
18.74
52-wk high
CNÂ¥138.30
52-wk low
CNÂ¥78.82
EPS
CNÂ¥5.95
No. of employees
2K
Open
CNÂ¥105.50
High
CNÂ¥112.36
Low
CNÂ¥105.20
Mkt. cap
50.21B
Avg. vol.
6.27M
Volume
0.00
Dividend
1.08%
Quarterly dividend
CNÂ¥0.30
Ex-dividend date
Sep 2, 2026
P/E ratio
18.74
52-wk high
CNÂ¥138.30
52-wk low
CNÂ¥78.82
EPS
CNÂ¥5.95
No. of employees
2K
News stories
From web sources and news partners
About Shanghai Allist Pharmaceuticals Co Ltd
CEO-
Employees2.27K
FoundedMar 22, 2004
Headquarters-
SectorPharmaceutical industry
Websiteallist.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.36B
1.45B
1.58B
1.74B
Cost of goods sold
45.38M
44.82M
80.59M
90.24M
Cost of revenue
45.38M
44.82M
80.59M
90.24M
Research and development expenses
112.23M
100.54M
113.72M
112.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
564.71M
651.83M
646.12M
667.07M
Operating expense
695.25M
771.29M
779.22M
805.13M
Total operating expenses
740.63M
816.11M
859.80M
895.38M
Operating income
618.62M
638.21M
723.97M
840.64M
Other non operating income
-3.11M
2.18M
-4.07M
4.51M
EBT including unusual items
653.24M
656.24M
741.46M
1.06B
EBT excluding unusual items
636.19M
652.61M
742.22M
861.81M
Income tax expense
88.70M
82.91M
105.41M
154.67M
Effective tax rate
13.58%
12.63%
14.22%
14.60%
Other operating expenses
18.47M
18.97M
20.01M
24.71M
Net income
564.54M
573.33M
636.04M
904.75M
Net profit margin
41.53%
39.42%
40.16%
52.12%
Earnings per share
-
-
-
-
Interest and investment income
19.56M
17.89M
22.35M
25.93M
Interest expense
-47.12K
-9.69K
-34.43K
-31.50K
Net interest expenses
19.52M
17.88M
22.32M
25.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
627.70M
648.03M
733.79M
852.49M
Gain or loss from assets sale
21.12K
-23.20K
-
-6.73K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps